Pure Global

LIAISON® CA 125 II - COFEPRIS Registration 2262R2019 SSA

Access comprehensive regulatory information for LIAISON® CA 125 II (LIAISON® CA 125 II) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 2262R2019 SSA and manufactured by DIASORIN MÉXICO S.A. DE C.V.. The device was registered on December 13, 2019.

This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase II
2262R2019 SSA
LIAISON® CA 125 II
COFEPRIS Analysis ID: 2262R2019 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Product Use / Uso del Producto
Spanish

REACTIVOS PARA LA DETERMINACIÓN CUANTITATIVA DEL ANTÍGENO CA 125

English

REAGENTS FOR THE QUANTITATIVE DETERMINATION OF CA 125 ANTIGEN

Device Classification
Risk Class / Clase de Riesgo
Clase II
Product Type (Spanish)
III. AGENTES DE DIAGNÓSTICO
Product Type (English)
III. DIAGNOSTIC AGENTS
Trade Name (Spanish)
REACTIVOS PARA LA DETERMINACIÓN CUANTITATIVA DEL ANTÍGENO CA 125
Trade Name (English)
REAGENTS FOR THE QUANTITATIVE DETERMINATION OF CA 125 ANTIGEN
Registration Information
Analysis ID
2262R2019 SSA
Registration Date
December 13, 2019
Manufacturer / Fabricante
Name (English)
DIASORIN MEXICO S.A. DE C.V.